> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Ceribell’s ClarityPro For Detecting Seizures
- URL: https://www.fdaweb.com/ceribells-claritypro-for-detecting-seizures/
- Published: 2023-08-11T12:00:00.000Z
- Updated: 2026-09-14T18:50:02.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5155079

FDA has cleared a Ceribell 510(k) for its new software ClarityPro for diagnosing electrographic status epilepticus (ESE) in adults. “The ability to diagnose ESE is essential to treating prolonged seizures, which may affect one-third of neurological critical care patients during their hospital stay,” the company says. “These seizures increase the risk of permanent brain injury with long-term neurological disability.”

Ceribell describes its point-of-care EEG \[electroencephalogram\] system as delivering real-time seizure monitoring and alerts 24/7\. The software uses a machine learning model to analyze EEG signals and generate bedside alerts, it says.